Zydus Lifesciences and MSN Laboratories have launched the first generic version of Bayer's Adempas (riociguat tablets) in the US across all five strengths after receiving USFDA approval, the companies announced on 5…
The Union health ministry has restricted the manufacture, sale and distribution of fixed-dose combinations containing chlorpheniramine maleate and phenylephrine hydrochloride for treating common cold symptoms in children below four years. Drugmakers must…
Zydus Lifesciences has received final approval from the U.S. Food and Drug Administration for its abbreviated new drug application for Ascorbic Acid Injection USP, used for short-term treatment of scurvy. The product…
